Direct Tax Adviser 1

Req ID:  219065

Edinburgh, GB, EH14 4AP Tranent, GB, EH33 2NE

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.


IMPORTANT:   In order to be considered for this position, a resume/CV must be uploaded and submitted during the application process.  Please make sure work history and education are added correctly.   

Job Summary


We are seeking a Direct Tax Adviser for our European Shared Services Accounting department located in Riccarton, Edinburgh.


The position of Direct Tax Adviser is a new position within the European Tax Team, which is part of a Global Tax Team. The European Tax Team currently consists of 3 people, covering both Direct and Indirect Taxes across the European Region. The role will report to the European Tax Manager but will also work closely with the Global Tax Team headquartered in Wilmington, US. Charles River allow flexible working so there may be opportunity for this role to be performed in part remotely.


This is a new role and will specifically support US GAAP and local Direct Tax compliance requirements for the European region, as well as assisting the European Tax Manager with project work and Tax advisory support to business operations. You will be required to build excellent relationships with key stakeholders and colleagues.


This is a hands-on role where the successful candidate is expected to be a self-starter enabled to support the European Tax Team from the outset.


The candidate should have a strong UK Corporation tax knowledge with an ability to deal with both Direct Tax compliance and advisory issues, gained through either in-house or international public practice experience.


The following are the main duties and responsibilities of the position:-


  • Manage the timely preparation of the UK and Ireland Corporation Tax compliance process, (US Group Reporting, (Quarterly, Interim and Final), Local Statutory reporting, CT payments on account, CT cashflow forecasts, RDEC calculations and Final Tax return filing and reconciliation process);
  • Provision of timely Direct Tax advice to business operations;
  • Maintenance of Direct Taxes Risk Register and testing of Direct Taxes Controls;
  • Assistance with other Key projects, (Transfer Pricing documentation, Legal entity rationalization and opening balance sheet Direct Tax Provisioning for new entity acquisitions);
  • Assistance with responding to Direct Tax communications with HMRC and Ireland Revenue Commissioners;
  • Preparation of Employer Share Scheme reporting for UK & Ireland;
  • Preparation of PAYE Settlement Agreement calculations and assistance with P11D returns.

The following are minimum requirements related to the position:-


  • Strong experience in UK Large Corporate Corporation Tax Compliance, gained either in-house, HMRC or in an international accounting
  • Qualified Accountant or Tax Adviser - ICAS, ACCA, CIMA, CTA
  • Intermediate Excel skills
  • Excellent knowledge of UK Corporate Tax legislation
  • Ability to digest Tax technical guidance and communicate to non-Tax technical colleagues
  • Fluency in written and spoken English language skills.
  • Proactive self-starter with proven ability to problem solve complex issues.
  • Excellent communicator and strong team player.
  • Strong research and analytical skills
  • Ability to build relationships at all levels

The salary for this position is negotiable depending on experience. 



IMPORTANT: A resume is required to be considered for this position. If you have not uploaded your resume in your candidate profile, please return to upload field and attach your resume/CV. 

About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities. 

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.

For more information, please visit